Predicted to act upstream of or within cholesterol homeostasis and negative regulation of bile acid biosynthetic process. Predicted to be located in Golgi apparatus. Orthologous to human MALRD1 (MAM and LDL receptor class A domain containing 1). [provided by Alliance of Genome Resources, Apr 2022]